Obstructive sleep apnea (OSA) is a common disorder characterized by repetitive collapse of the upper airway during sleep. Given that excess adiposity is a known risk factor for OSA, we aimed to descriptively assess the association of tirzepatide, a GIP/GLP-1 receptor agonist, with changes in AHI, hypoxic burden, body w...
Beverly L. Falcon, C. Xie, S. Redline et al.· Journal of Clinical Sleep Me...· 0 citations
In this indirect treatment comparison for obesity treatment in adults without T2D, with obesity, or overweight with ≥1 ORC, compared with semaglutide, tirzepatide 10 or 15’mg was associated with improvements in weight reduction, body composition and several cardiometabolic risk factors and generally similar safety prof...
A. Ciudin, Erin Johansson, S. Zimner-Rapuch et al.· International Journal of Obe...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.